✦ LIBER ✦

5002 MoniCa: A multicenter phase II study to determine the efficacy of capecitabine as first line monochemotherapy in patients with HER2 negative, medium-risk, metastatic breast cancer (GBG39)

✍ Scribed by M. Kaufmann; M.W. Sütterlin; I. Schrader; B. Gerber; W. Bauer; C. Mundhenke; W. Wiest; K. Mehta; S. Loibl; G. von Minckwitz

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multicenter phase I–II study of doceta

✍ Tryfonidis, K.; Boukovinas, I.; Xenidis, N.; Christophyllakis, C.; Papakotoulas, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 348 KB

A Phase II Trial of Split, Low-Dose Doce

✍ Orlando Silva; Gilberto Lopes; Daniel Morgenzstern; Christopher Lobo; Philomena 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 116 KB

470 Final results of a phase II study of

✍ S. Glück; C. Lobo; G. Lopes; A. Castrellon; J. Hurley; I. Reis; S. Richman; O. S 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 49 KB

A phase II open-label randomized study t

✍ György Bodoky, Constanta Timcheva, David Robert Spigel, Phillip Joseph La Stella 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 640 KB

Erratum to: A phase II open-label random

✍ György Bodoky, Constanta Timcheva, David Robert Spigel, Phillip Joseph La Stella 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 61 KB